Pharma & Biotech
Sustainability
Cannabis
Battery Metals
Artificial Intelligence
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Content on the Site is provided for information purposes only, and none of the information contained on the Site constitutes an offer, solicitation or recommendation to buy or sell a security. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume which any Content on the Site may generate. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, suitability or profitability of any particular security, portfolio of securities, transaction, investment, investment strategy, or other matter. You understand…
William kickstarted his career as a researcher and reporter for a global legal publication, covering everything from public law to M&A. Before moving to Proactive Investors, he worked as a reporter for a major fintech company with a focus on cryptocurrency and blockchain technology. Harking from Queensland, Australia, William obtained first-class honours in journalism and media from Birkbeck University before going on to complete an MA in creative and critical writing. Other jobs have… Read more
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
Published: 02:54 21 Oct 2024 EDT
Sky UK ran up an operating loss of £224 million in 2023, representing a more than 100% increase in losses compared to the previous year, according to recently filed Companies House documents.
The broadcaster, which is owned by US cable giant Comcast, reported elevated programming costs of £3.5 billion attributed to the Qatar World Cup football season.
Sky also recognised an impairment charge of £1.2 billion due to investments made in its German and Italian operations.
Sky added that sales, general and administration (SGA) costs increased due to higher hardware costs in the mobile space.
These additional expenses did not come with higher revenues, which stayed flat at £10.2 billion.
Although direct-to-consumer sales ticked up to £8.5 billion from £8.36 billion in 2022, this was offset by lower advertising income, reflecting a broader trend of reduced marketing spend amid the cost-of-living crisis.
Comcast acquired Sky in 2018 for $39 billion (£39 billion) following a bidding war with 21st Century Fox.
Sign up to receive alerts and news direct to your inbox
Vivos Therapeutics (NASDAQ:VVOS) CEO Kirk Huntsman joined Steve Darling from Proactive to discuss significant milestone with the FDA clearance of their oral appliance for treating obstructive sleep apnea (OSA) in children aged 6 to 17, particularly those requiring orthodontic treatment. This…
Copyright © Proactive Group Holdings Inc, 2024
All Rights Reserved – Proactive North America Inc., Proactive Investors LLC.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.
